NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

Apr 09, 2020

|

NEW YORK – NeoGenomics reported on Thursday that its preliminary revenues for the first quarter of 2020 are expected to increase 11 percent year over year to $106 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

To read the full story....

Breaking News

People in the News: New Appointments at Qiagen, ImmunoScape, 908 Devices, More

New Products Posted to GenomeWeb: Twist Bioscience, New England Biolabs, Promega, More

In Brief This Week: Thermo Fisher Scientific, Fourth Circuit Court of Appeals, Invitae, and More

GenDx HLA Genotyping Products Receives Health Canada IVD Approval

Personalis Q4 Revenues up 11 Percent

Natera Revenues Grow 35 Percent in Q4

Recent Headlines from
Precision Oncology News

Cartesian Therapeutics Bets on mRNA Engineering for Moving CAR T Cells Into Frontline Treatment

Elicio Therapeutics Sharpens Development Plan for Cancer Vaccine in KRAS-Mutated Tumors

CAR T-Cell Resistance Mechanism Shows Need for Multi-Antigen Targeted Immunotherapy Strategies

Benefit of AstraZeneca's Cediranib Plus Lynparza May Be Limited to HRR-Deficient Prostate Cancers

Fecal Transplants Boost Immunotherapy Response in Subset of Melanoma Patients

The Scan

Even Bigger

Got Into the Lab Machines

Not Going to Pay

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

What's Popular?

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

People in the News: New Appointments at Qiagen, ImmunoScape, 908 Devices, More

Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

10x Genomics Acquires Denmark's Tetramer Shop

Sponsorships